| Authors: |
Dalvin LA; Departments of Ophthalmology, Mayo Clinic, Rochester, MN, USA.; Medical Oncology, Mayo Clinic, Rochester, MN, USA.; School of Medicine, Deakin University, Geelong, VIC, Australia.; Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, VIC, Australia., Kopinski PK; Departments of Ophthalmology, Mayo Clinic, Rochester, MN, USA., Miley DR; Departments of Ophthalmology, Mayo Clinic, Rochester, MN, USA., Ong H; Departments of Ophthalmology, Mayo Clinic, Rochester, MN, USA., Erickson SA; Departments of Ophthalmology, Mayo Clinic, Rochester, MN, USA., Andrews-Pfannkoch CM; Departments of Ophthalmology, Mayo Clinic, Rochester, MN, USA., Burr SD; Departments of Ophthalmology, Mayo Clinic, Rochester, MN, USA., Armitage JA; School of Medicine, Deakin University, Geelong, VIC, Australia.; Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, VIC, Australia. |